Doctors didn't disclose spine product cancer risk in journal
Doctors paid millions of dollars by Medtronic failed to identify a significant cancer risk with the company's spine surgery product in a 2009 paper about results of a large clinical trial. (MILWAUKEE JOURNAL SENTINEL, 10/24)
To access this content, you must purchase a Premium membership, or log in if you are a member.
